ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00386399
Recruitment Status : Withdrawn (All 29 consented subjects tested negative for the BRCA2 mutation. None started study, so PI decided to close the study.)
First Posted : October 11, 2006
Last Update Posted : October 8, 2015
Sponsor:
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : February 2008
  Actual Study Completion Date : February 2008